VINCENT DEPARTMENT OF OBSTETRICS AND GYNECOLOGY


Meet Vincent Fellows 2023–24

With support from The Vincent Memorial Hospital Foundation, the Vincent Department of OB/GYN offers 12 fellowships in four subspecialties, serving as a professional springboard for young physician-scientists to pursue the demanding training that will help them become tomorrow’s leaders in academic medicine. The physicians below conducted innovative studies during the research year of their three-year fellowship, focusing on key questions in women’s healthcare.

Resistance to 'Antibody Drug Conjugate Therapy' in Ovarian Cancer

Resistance to 'Antibody Drug Conjugate Therapy' in Ovarian Cancer

William Manning, MD, a Vincent fellow in Gynecologic Oncology, is investigating the mechanisms of resistance to antibody drug conjugate (ADC) therapy in ovarian cancer, which combines an antibody to a specific tumor-associated target with a cytotoxic payload taken up by the tumor cells upon binding.

LEARN MORE

Association Between Vaginal <i>Lactobacillus</i> Species, Cytokine Activity and Overactive Bladder Symptoms

Association Between Vaginal Lactobacillus Species, Cytokine Activity and Overactive Bladder Symptoms

Elizabeth Hoover Dotson, DO, a Vincent fellow in Female Pelvic Medicine and Reconstructive Surgery (Urogynecology), is examining the association between vaginal Lactobacillus species, cytokine activity and overactive bladder symptoms among postmenopausal women.

LEARN MORE

Impact of Screening and Treatment for Iron Deficiency on Birth Outcomes and the Patient Experience

Impact of Screening and Treatment for Iron Deficiency on Birth Outcomes and the Patient Experience

Logan Mauney, MD, a Vincent Fellow in Maternal-Fetal Medicine, is studying how screening and treatment of iron deficiency in the third trimester of pregnancy impacts birth outcomes and the patient experience.

LEARN MORE

Effect of Anti-Müllerian Hormone on Human Pre-Implantation Embryos and How Pre-Implantation Genetics Differ Amongst Patients with PCOS

Effect of Anti-Müllerian Hormone on Human Pre-Implantation Embryos and How Pre-Implantation Genetics Differ Amongst Patients with PCOS

Christopher Ke Arkfeld, MD, a Vincent fellow in Reproductive Endocrinology and Infertility, in the basic science lab is investigating the role of anti-Müllerian hormone (AMH) on human pre-implantation embryos across different infertility diagnoses including polycystic ovarian syndrome (PCOS). His clinical research interests focus on improving patient experiences and outcomes at Mass General’s Fertility Center.

LEARN MORE